Marine’s widow seeks justice after her husband’s death, saying it was caused by exposure to contaminated drinking water at ...

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

A new independent academic study examining a form of blood cancer among those who served at Malmstrom Air Force Base, Montana ...

A mistrial was declared Tuesday after jurors awarded a retired truck driver a total of $70 million in his lawsuit against the owner of a Covington sterilization facility.

A new Brazilian-developed CAR-T cell therapy has shown extraordinary results in treating refractory CD30+ lymphoma, including ...

According to the National Institutes of Health, this type of cancer makes up less than five percent of all lymphoma cases worldwide. “There are a lot of illnesses where you can talk confidently ...

They range from slow-growing cancers to aggressive, fast-growing forms. Most cases of lymphoma are usually considered treatable. But it’s still a serious disease that requires medical attention.

A Phase I trial involving ten patients with relapsed or refractory classical Hodgkin lymphoma or T-cell lymphoma has achieved ...

Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the ...

In a Phase 1 clinical trial, a CAR T-cell therapy targeting the CD30 protein has been shown to promote the expansion of ...

China’s National Medical Products Administration (NMPA) has approved InnoCare Pharma’s Bruton's tyrosine kinase (BTK) ...

Researchers at Children's Hospital of Philadelphia (CHOP) highlighted the success of anaplastic lymphoma kinase (ALK) ...